IPO Boutique

Trivascular Technologies, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Trivascular Technologies, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Trivascular Technologies, Inc.TRIV -
NASDAQ
$13.00-$15.00 $12.00 $11.356.5 million4/16/2014
J.P. Morgan, Credit Suisse
Co-Manager(s):
Canaccord Genuity, Stifel
Health Care
Filing(s):

Filed 2014-03-10
Terms Added 2014-04-03



Trivascular Technologies, Inc. Quote & Chart - Click for current quote - TRIV

About Trivascular Technologies, Inc. (adapted from Trivascular Technologies, Inc. prospectus):
They are a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms, or AAA.

This description is adapted from Trivascular TRIV prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Trivascular TRIV "TRIV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved